Sfoglia per Autore
Challenges in identifying paediatric cancer predisposition syndromes: international SCOPE survey and SIOPE expert consensus recommendations
2026 Cavar Pavic, J; Cullinan, N; Jongmans, M; Bourdeaut, F; Wadt, K; Lonigro, L; Davies, M; Michaeli, O; Strang-Karlsson, S; De Putter, R; Sepulchre, E; Cazzaniga, G; Furtwangler, R; Zweier, C; Rossler, J; Waespe, N
Targeting oncogene-induced senescence in ETV6::RUNX1 pre-leukemic cells
2026 Acunzo, D; Bertagna, M; Risca, G; Beneforti, L; Bresolin, S; Galimberti, S; Sanchez-Garcia, I; Biondi, A; Cazzaniga, G; Palmi, C
Cytopenia, Hypocellular Bone Marrow, and Shortened Telomere Length Beyond Biallelic Telomere Biology Gene Mutations
2026 Franco, G; Bruno, L; Alviano, A; Vankann, L; Brümmendorf, T; Guerra, F; Vendemini, F; Faverio, P; L’Imperio, V; Cazzaniga, G; Luppi, F; Biondi, A; Balduzzi, A; Beier, F; Saettini, F
PEDIATRIC PAX5-REARRANGED ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) IS A HIGH-RISK MOLECULAR SUBGROUP OF B-ALL WITH A POOR MRD-DEPENDENT PROGNOSTIC PROFILE
2026 Peccatori, N; Curto, A; Silvestri, D; Rebellato, S; Antic, Z; Bhatia, S; Bergmann, A; Borkhardt, A; Zimmermann, M; Strehl, S; Nebral, K; Saitta, C; Quadri, M; Palmi, C; Bardini, M; Guardo, D; Lo Nigro, L; Parasole, R; Putti, M; Locatelli, F; Alten, J; Stanulla, M; Valsecchi, M; Buldini, B; Conter, V; Biondi, A; Balduzzi, A; Schrappe, M; Attarbaschi, A; Cario, G; Rizzari, C; Cazzaniga, G; Fazio, G
A multi-dimensional approach to recognize genetic predisposition in children with acute lymphoblastic leukemia
2025 Junk, S; Bettini, L; Daugs, K; Mescher, M; Jongmans, M; Borkhardt, A; Cazzaniga, G; Kuiper, R; Bakhuizen, J
A novel RTEL1 nonsense variant in a case of familial pulmonary fibrosis: clinical description and genetic implications
2025 Franco, G; Bertola, F; Aloisi, F; Promi, S; Zanini, U; Faverio, P; Bentivegna, A; Borie, R; Crestani, B; Cazzaniga, G; Luppi, F
Exploring glioblastoma heterogeneity: the impact of ecDNA on tumor evolution and progression
2025 Ghizzi, M; Sirtori, A; Ripamonti, G; Sala, C; Gautiero, E; Sala, E; Redaelli, S; Cazzaniga, G; Bentivegna, A
Overt and covert genetic causes of pediatric acute lymphoblastic leukemia: ACUTE LYMPHOBLASTIC LEUKEMIA
2025 Stoltze, U; Junk, S; Byrjalsen, A; Cave, H; Cazzaniga, G; Elitzur, S; Fronkova, E; Hjalgrim, L; Kuiper, R; Lundgren, L; Mescher, M; Mikkelsen, T; Pastorczak, A; Strullu, M; Trka, J; Wadt, K; Izraeli, S; Borkhardt, A; Schmiegelow, K
PAX5::AUTS2 childhood B-ALL: a relapse-prone genetic subtype with frequent central nervous system involvement and a poor outcome: ACUTE LYMPHOBLASTIC LEUKEMIA
2025 Caye-Eude, A; Fazio, G; Pastorczak, A; Boer, J; Steinemann, D; Ganguli, D; Sonneveld, E; Haslinger, S; D'Andrea, L; Bradtke, J; Lopes, B; Zaliova, M; Escherich, G; König, M; Fortschegger, K; Inthal, A; Stasevich, I; Emerenciano, M; Trka, J; Castillo, L; Parihar, M; Moorman, A; Bergmann, A; den Boer, M; Młynarski, W; Cazzaniga, G; Cavé, H; Nebral, K; Schinnerl, D; Strehl, S
First-Tier Versus Last-Tier Trio Whole-Genome Sequencing for the Diagnosis of Pediatric-Onset Rare Diseases
2025 Lucca, C; Rosina, E; Pezzani, L; Piazzolla, D; Spaccini, L; Scatigno, A; Gasperini, S; Pezzoli, L; Cereda, A; Milani, D; Cattaneo, E; Cavallari, U; Frigeni, M; Marchetti, D; Daolio, C; Giordano, L; Bellini, M; Goisis, L; Mongodi, C; Tonduti, D; Pilotta, A; Cazzaniga, G; Furlan, F; Bedeschi, M; Mangili, G; Bonanomi, E; Iascone, M
HDAC7 induction combined with standard-of-care chemotherapy provides a therapeutic advantage in t(4;11) infant B-cell acute lymphoblastic leukemia
2025 De Barrios, O; Ocón-Gabarró, I; Gusi-Vives, M; Collazo, O; Meler, A; Romecín, P; Martínez-Moreno, A; Tejedor, J; Fraga, M; Schneider, P; Bardini, M; Cazzaniga, G; Marschalek, R; Stam, R; Bueno, C; Menéndez, P; Parra, M
Donor-derived CARCIK-CD19 cells engineered with Sleeping Beauty transposon in acute lymphoblastic leukemia relapsed after allogeneic transplantation
2025 Lussana, F; Magnani, C; Galimberti, S; Gritti, G; Gaipa, G; Belotti, D; Cabiati, B; Napolitano, S; Ferrari, S; Moretti, A; Buracchi, C; Borleri, G; Rambaldi, B; Rizzuto, G; Grassi, A; Paganessi, M; Meli, C; Tettamanti, S; Risca, G; Pais, G; Spinozzi, G; Benedicenti, F; Cazzaniga, G; Capelli, C; Gotti, E; Introna, M; Golay, J; Montini, E; Balduzzi, A; Valsecchi, M; Dastoli, G; Rambaldi, A; Biondi, A
Biallelic PI4KA Mutations Disrupt B-Cell Metabolism and Cause B-Cell Lymphopenia and Hypogammaglobulinemia
2025 Saettini, F; Guerra, F; Mauri, M; Salter, C; Adam, M; Adams, D; Baple, E; Barredo, E; Bhatia, S; Borkhardt, A; Brusco, A; Bugarin, C; Chinello, C; Crosby, A; D'Souza, P; Denti, V; Fazio, G; Giuliani, S; Kuehn, H; Amel, H; Elmi, A; Lo, B; Malighetti, F; Mandrile, G; Martín-Nalda, A; Mefford, H; Moratto, D; Emam Mousavi, F; Nelson, Z; Gutiérrez-Solana, L; Macnamara, E; Michaud, V; O'Leary, M; Pagani, L; Pavinato, L; Santamaria, P; Planas-Serra, L; Quadri, M; Raspall-Chaure, M; Rebellato, S; Rosenzweig, S; Roubertie, A; Holzinger, D; Deal, C; Vockley, C; Savino, A; L. Stoddard, J; Uhlig, H; Pujol, A; Magni, F; Paglia, G; Cazzaniga, G; Piazza, R; Barberis, M; Biondi, A
Cohesins: Crossroad Between Cornelia de Lange Spectrum and Cancer Predisposition
2025 Rigotti, L; Rebellato, S; Lettieri, A; Castiglioni, S; Mariani, M; Totaro, S; Saitta, C; Gervasini, C; Fazio, G; Massa, V; Cazzaniga, G; Selicorni, A
Minimal Residual Disease in Paediatric ALL: Significance and Methodological Approaches
2024 Trka, J; Reiterova, M; Cazzaniga, G; Fronkova, E
First-Hit SETBP1 Mutations Cause a Myeloproliferative Disorder with Bone Marrow Fibrosis Mimicking Triple Negative Myelofibrosis
2024 Fontana, D; Crespiatico, I; Zaghi, M; Mastini, C; D’Aliberti, D; Mauri, M; Mercado, C; Spinelli, S; Crippa, V; Inzoli, E; Manghisi, B; Civettini, I; Ramazzotti, D; Sangiorgio, V; Gengotti, M; Brambilla, V; Aroldi, A; Banfi, F; Barone, C; Orsenigo, R; Riera, L; Riminucci, M; Corsi, A; Breccia, M; Morotti, A; Cilloni, D; Roccaro, A; Sacco, A; Stagno, F; Serafini, M; Mottadelli, F; Cazzaniga, G; Pagni, F; Chiarle, R; Azzoni, E; Sessa, A; Gambacorti-Passerini, C; Elli, E; Mologni, L; Piazza, R
First-hit SETBP1 mutations cause a myeloproliferative disorder with bone marrow fibrosis
2024 Crespiatico, I; Zaghi, M; Mastini, C; D'Aliberti, D; Mauri, M; Mercado, C; Fontana, D; Spinelli, S; Crippa, V; Inzoli, E; Manghisi, B; Civettini, I; Ramazzotti, D; Sangiorgio, V; Gengotti, M; Brambilla, V; Aroldi, A; Banfi, F; Barone, C; Orsenigo, R; Riera, L; Riminucci, M; Corsi, A; Breccia, M; Morotti, A; Cilloni, D; Roccaro, A; Sacco, A; Stagno, F; Serafini, M; Mottadelli, F; Cazzaniga, G; Pagni, F; Chiarle, R; Azzoni, E; Sessa, A; Gambacorti Passerini, C; Elli, E; Mologni, L; Piazza, R
Synergistic drug interactions of the histone deacetylase inhibitor givinostat (ITF2357) in CRLF2-rearranged pediatric B-cell precursor acute lymphoblastic leukemia identified by high-throughput drug screening
2024 Oikonomou, A; Watrin, T; Valsecchi, L; Scharov, K; Savino, A; Schliehe-Diecks, J; Bardini, M; Fazio, G; Bresolin, S; Biondi, A; Borkhardt, A; Bhatia, S; Cazzaniga, G; Palmi, C
Distinct pattern of genomic breakpoints in CML and BCR::ABL1-positive ALL: analysis of 971 patients
2024 Hovorkova, L; Winkowska, L; Skorepova, J; Krumbholz, M; Benesova, A; Polivkova, V; Alten, J; Bardini, M; Meyer, C; Kim, R; Trahair, T; Clappier, E; Chiaretti, S; Henderson, M; Sutton, R; Sramkova, L; Stary, J; Polakova, K; Marschalek, R; Metzler, M; Cazzaniga, G; Cario, G; Trka, J; Zaliova, M; Zuna, J
Analysis of measurable residual disease by IG/TR gene rearrangements: quality assurance and updated EuroMRD guidelines
2024 van der Velden, V; Dombrink, I; Alten, J; Cazzaniga, G; Clappier, E; Drandi, D; Eckert, C; Fronkova, E; Hancock, J; Kotrova, M; Kraemer, R; Montonen, M; Pfeifer, H; Pott, C; Raff, T; Trautmann, H; Cave, H; Schafer, B; van Dongen, J; Trka, J; Bruggemann, M; van der Velden, V; Raff, T; van Dongen, J
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile